Livingstone Health (SGX:PRH) will invest in a 30% stake in MetEndo or the Metabolic Clinic, according to a filing with the Singapore Exchange on Monday.
MetEndo is an endocrine specialist clinic, which provides comprehensive and holistic expert consultations to patients.
Through the partnership, Livingstone is targeting cross-collaboration between its healthcare professionals and network of practitioners.
The company's medical director, Dinesh Carl Junis Mahendran, owns a 70% stake in The Metabolic Clinic which will start its operations in June this year.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。